5-amino-1mq and cd38 inhibitor synergy nad+ Targeting CD38-dependent metabolism to mitigate multiple organ fibrosis New Insights on Muscle Strength:
New Insights on Muscle Strength: The Role of Inhibiting an Enzyme that Hinders NAD+ Synthesis Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS driven AML: Cell Metabolism The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22




